Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Argus Health
Baxter
Healthtrust
Deloitte
UBS
QuintilesIMS
Medtronic
Fish and Richardson
McKesson

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050632

« Back to Dashboard
NDA 050632 describes AZACTAM IN PLASTIC CONTAINER, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. Additional details are available on the AZACTAM IN PLASTIC CONTAINER profile page.

The generic ingredient in AZACTAM IN PLASTIC CONTAINER is aztreonam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aztreonam profile page.

Summary for NDA: 050632

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050632

Ingredient-typeMonobactams

Suppliers and Packaging for NDA: 050632

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZACTAM IN PLASTIC CONTAINER
aztreonam
INJECTABLE;INJECTION 050632 NDA E.R. Squibb & Sons, L.L.C. 0003-2230 0003-2230-11 24 CONTAINER in 1 PACKAGE (0003-2230-11) > 50 mL in 1 CONTAINER
AZACTAM IN PLASTIC CONTAINER
aztreonam
INJECTABLE;INJECTION 050632 NDA E.R. Squibb & Sons, L.L.C. 0003-2240 0003-2240-11 24 CONTAINER in 1 PACKAGE (0003-2240-11) > 50 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/ML
Approval Date:May 24, 1989TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:May 24, 1989TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:May 24, 1989TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Fuji
Citi
Express Scripts
Deloitte
Argus Health
Accenture
Medtronic
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot